|
|
||||||||||
|
Click on image to view larger version.
Figure 3 Use percentage of patients showing a
6 mEq/l increase in serum sodium or normal serum sodium at the end of intravenous conivaptan (CNV) treatment. *p = 0.0359;
p = 0.0025;
p = 0.032;
p = 0.0023 vs. placebo from Cochran-Mantel-Haenszel test. Adapted with permission (8). HF = heart failure.
|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |